Neurelis INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSan Diego, CA
US patents6
SAM.gov UEILHACH46DW2N1
CAGE code8PDM4
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
6 US patents granted 2022–2025, 6 of them in the five years to SEP 2025.
Pharmaceuticals 6
- Administration of benzodiazepine compositionsUS 12,337,061 · granted JUN 24, 2025
- Administration of benzodiazepine compositionsUS 12,324,852 · granted JUN 10, 2025
- Administration of benzodiazepine compositionsUS 12,268,664 · granted APR 8, 2025
- Intranasal olanzapine formulations and methods of their useUS 12,171,868 · granted DEC 24, 2024
- Administration of benzodiazepine compositionsUS 11,793,786 · granted OCT 24, 2023
Newest 5 shown · Granted to Neurelis, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Neurelis INC | San Diego | CA | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.